[1] Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence [published correction appears in Circulation. 2006 Sep 12; 114(11):e498]. Circulation 2006; 114: 119−125. doi: 10.1161/CIRCULATIONAHA.105.595140 [2] Kornej J, Börschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res 2020; 127: 4−20. doi: 10.1161/CIRCRESAHA.120.316340 [3] [4] Borschel CS, Schnabel RB. The imminent epidemic of atrial fibrillation and its concomitant diseases—myocardial infarction and heart failure—a cause for concern. Int J Cardiol 2019; 287: 162−173. doi: 10.1016/j.ijcard.2018.11.123 [5] Brugada R, Tapscott T, Czernuszewicz GZ, et al. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336: 905−911. doi: 10.1056/NEJM199703273361302 [6] Roberts JD, Gollob MH. A contemporary review on the genetic basis of atrial fibrillation. Methodist Debakey Cardiovasc J 2014; 10: 18−24. doi: 10.14797/mdcj-10-1-18 [7] Rangnekar G. The characterisation of risk factors, substrate and management strategies for atrial fibrillation. https://hdl.handle.net/2440/96728 (accessed on January 21, 2023). [8] [9]

Chamberlain AM, Agarwal SK, Folsom AR, et al. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm. 2011; 8: 1160–1166.

[10] GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022; 7: e105−e125. doi: 10.1016/S2468-2667(21)00249-8 [11] [12] [13] Kostopoulou O, Delaney BC, Munro CW. Diagnostic difficulty and error in primary care-a systematic review. Family Practice 2008; 25: 400−413. doi: 10.1093/fampra/cmn071 [14] Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab 2016; 36: 172−186. doi: 10.1038/jcbfm.2015.164 [15] Baumgart M, Snyder HM, Carrillo MC, et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement 2015; 11: 718−726. doi: 10.1016/j.jalz.2015.05.016 [16]

Rivard L, Friberg L, Conen D, et al. Atrial fibrillation and dementia: a report from the AF-SCREEN International Collaboration [published correction appears in Circulation. 2022 Apr 19; 145(16):e842]. Circulation 2022; 145: 392−409.

[17] Proietti R, AlTurki A, Vio R, et al. The association between atrial fibrillation and Alzheimer's disease: fact or fallacy? A systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 2020; 21: 106−112. doi: 10.2459/JCM.0000000000000917 [18] Troncone L, Luciani M, Coggins M, et al. Aβ amyloid pathology affects the hearts of patients with alzheimer's disease: mind the heart. J Am Coll Cardiol 2016; 68: 2395−2407. doi: 10.1016/j.jacc.2016.08.073 [19] Rosenberg MA, Manning WJ. Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal. Circulation 2012; 126: 2353−2362. doi: 10.1161/CIRCULATIONAHA.112.113233 [20] Anselmino M, Scarsoglio S, Saglietto A, et al. Transient cerebral hypoperfusion and hypertensive events during atrial fibrillation: a plausible mechanism for cognitive impairment. Sci Rep 2016; 6: 28635. doi: 10.1038/srep28635 [21] [22] Bell RD, Zlokovic BV. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009; 118: 103−113. doi: 10.1007/s00401-009-0522-3 [23] Gaita F, Corsinovi L, Anselmino M, et al. Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. J Am Coll Cardiol 2013; 62: 1990−1997. doi: 10.1016/j.jacc.2013.05.074 [24] Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta 2016; 1862: 915−925. doi: 10.1016/j.bbadis.2016.01.015 [25] Giannone ME, Filippini T, Whelton PK, et al. Atrial fibrillation and the risk of early-onset dementia: a systematic review and meta-analysis. J Am Heart Assoc 2022; 11: e025653. doi: 10.1161/JAHA.122.025653 [26] Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383−421. doi: 10.1016/S0197-4580(00)00124-X [27] Korantzopoulos P, Kalantzi K, Siogas K, Goudevenos JA. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion. Pacing Clin Electrophysiol 2008; 31: 1272−1276. doi: 10.1111/j.1540-8159.2008.01177.x [28]

Takeda S, Sato N, Morishita R. Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci 2014; 6: 171.

[29] Ballatore A, Matta M, Saglietto A, et al. Subclinical and asymptomatic atrial fibrillation: current evidence and unsolved questions in clinical practice. Medicina (Kaunas) 2019; 55: 497. doi: 10.3390/medicina55080497 [30] McCallum CJ, Raja DC, Pathak RK. Atrial fibrillation: an update on management. Aust Prescr 2019; 42: 186−191. doi: 10.18773/austprescr.2019.067 [31] Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: a review. JAMA 2019; 322: 1589. doi: 10.1001/jama.2019.4782 [32] Li X, Yuan J, Yang L, et al. The significant effects of cerebral microbleeds on cognitive dysfunction: an updated meta-analysis. PLoS One 2017; 12: e0185145. doi: 10.1371/journal.pone.0185145 [33] Haeusler KG, Wilson D, Fiebach JB, et al. Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives. Heart 2014; 100: 1408−1413. doi: 10.1136/heartjnl-2013-305151 [34]

Li J, Gao M, Zhang M, et al. Treatment of atrial fibrillation: a comprehensive review and practice guide. Cardiovasc J Afr 2020; 31: 153−158.

[35] Kim D, Yang PS, Sung JH, et al. Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. Eur Heart J 2020; 41: 4483−4493. doi: 10.1093/eurheartj/ehaa726 [36] Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 2016; 50: e1−e88. doi: 10.1093/ejcts/ezw313 [37]

Diener HC, Hart RG, Koudstaal PJ, et al. Atrial fibrillation and cognitive function: JACC Review Topic of the Week. J Am Coll Cardiol. 2019; 73: 612–619.

[38] Gardarsdottir M, Sigurdsson S, Aspelund T, et al. Improved brain perfusion after electrical cardioversion of atrial fibrillation. Europace 2020; 22: 530−537. doi: 10.1093/europace/euz336 [39] Chen LY, Norby FL, Gottesman RF, et al. Association of atrial fibrillation with cognitive decline and dementia over 20 years: the ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study). J Am Heart Assoc 2018; 7: e007301. doi: 10.1161/JAHA.117.007301 [40] Bunch TJ, Weiss JP, Crandall BG, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia. Heart Rhythm 2010; 7: 433−437. doi: 10.1016/j.hrthm.2009.12.004 [41] Marzona I, O’Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ 2012; 184: E329−E336. doi: 10.1503/cmaj.111173 [42]

Ott A, Breteler MM, de Bruyne MC, et al. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997; 28: 316−321.